216 results on '"Kugeler, Kiersten J."'
Search Results
2. Surveillance for Lyme Disease After Implementation of a Revised Case Definition--United States, 2022
3. Epidemiologic and tick exposure characteristics among people with reported Lyme disease – Minnesota, 2011–2019
4. Predicting distributions of blacklegged ticks (Ixodes scapularis), Lyme disease spirochetes (Borrelia burgdorferi sensu stricto) and human Lyme disease cases in the eastern United States
5. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January–March 2021
6. Pregnancy Among Reported Lyme Disease Cases—United States, 1992–2019.
7. Characteristics of Hard Tick Relapsing Fever Caused by Borrelia miyamotoi, United States, 2013-2019.
8. Intervention To Stop Transmission of Imported Pneumonic Plague — Uganda, 2019
9. Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010-2018
10. Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010-2018
11. Tularemia Clinical Manifestations, Antimicrobial Treatment, and Outcomes: An Analysis of US Surveillance Data, 2006–2021
12. Engagement with Traditional Healers for Early Detection of Plague in Uganda
13. Animal Exposure and Human Plague, United States, 1970-2017
14. Effects of COVID-19 Pandemic on Reported Lyme Disease, United States, 2020
15. Surveillance for and Discovery of Borrelia Species in US Patients Suspected of Tickborne Illness
16. Surveillance for Lyme Disease — United States, 2008–2015
17. Knowledge and practices related to plague in an endemic area of Uganda
18. Soft Tick Relapsing Fever — United States, 2012–2021
19. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving >1 JYNNEOS Vaccine Dose-32 U.S. Jurisdictions, July 31-September 3, 2022
20. Epidemiology of Lyme disease in low-incidence states
21. Patterns of human plague in Uganda, 2008-2016
22. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022
23. Lyme disease in Hispanics, United States, 2000-2013
24. No geographic correlation between Lyme disease and death due to 4 neurodegenerative disorders, United States, 2001-2010
25. Incidence of clinician-diagnosed Lyme disease, United States, 2005-2010
26. Epidemiology of human plague in the United States, 1900-2012
27. Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–July, 2021
28. Potential quantitative effect of a laboratory‐based approach to Lyme disease surveillance in high‐incidence states
29. Additional file 1 of Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January–March 2021
30. Surveillance for Lyme Disease — United States, 1992-2006
31. Characteristics of Reported Deaths Among Fully Vaccinated Persons With Coronavirus Disease 2019—United States, January–April 2021
32. Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July–August 2020
33. Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States—January–April, 2021
34. Changing Trends in Age and Sex Distributions of Lyme Disease—United States, 1992-2016
35. Changing socioeconomic indicators of human plague, New Mexico, USA
36. Geographic distribution and expansion of human lyme disease, United States
37. Molecular epidemiology of Francisella tularensis in the United States
38. Changing Trends in Age and Sex Distributions of Lyme Disease—United States, 1992-2016.
39. Characteristics of Reported Deaths Among Fully Vaccinated Persons With Coronavirus Disease 2019—United States, January–April 2021.
40. Epidemiology and cost of Lyme disease‐related hospitalizations among patients with employer‐sponsored health insurance—United States, 2005–2014
41. Antimicrobial Treatment Patterns and Illness Outcome Among United States Patients With Plague, 1942–2018
42. Challenges in Predicting Lyme Disease Risk
43. Francisella opportunistica sp. nov., isolated from human blood and cerebrospinal fluid
44. An Evaluation of the Flea Index as a Predictor of Plague Epizootics in the West Nile Region of Uganda
45. Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July–August 2020.
46. Real-time PCR for Francisella tularensis types A and B
47. Human tularaemia associated with exposure to domestic dogs—United States, 2006–2016
48. A Cross-Cutting Approach to Surveillance and Laboratory Capacity as a Platform to Improve Health Security in Uganda
49. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates
50. Rat Fall Surveillance Coupled with Vector Control and Community Education as a Plague Prevention Strategy in the West Nile Region, Uganda
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.